Export 41 results:
Author Title [ Type(Asc)] Year
Filters: Author is Damas, A.M.  [Clear All Filters]
Journal Article
Neto-Silva, R. M., Macedo-Ribeiro, S., Pereira, P. J. B., Coll, M., et al. (2005). X-ray crystallographic studies of two transthyretin variants: Further insights into amyloidogenesis. Acta Crystallographica Section D: Biological Crystallography, 61(3), 333 - 339.
Gales, L., & Damas, A. M. (2005). Xanthones - A structural perspective. Current Medicinal Chemistry, 12(21), 2499 - 2515.
Martins, P. M., Ferreira, A., Polanco, S., Rocha, F., et al. (2009). Unsteady-state transfer of impurities during crystal growth of sucrose in sugarcane solutions. Journal of Crystal Growth, 311(15), 3841 - 3848.
Martins, P. M., Rocha, F., Damas, A. M., & Rein, P. (2011). Unsteady-state inhibition of crystal growth caused by solution impurities. CrystEngComm, 13(4), 1103 - 1110.
Martins, P. M., Rocha, F., & Damas, A. M. (2008). Understanding water equilibration fundamentals as a step for rational protein crystallization. PLoS ONE, 3(4).
Liz, M. A., Leite, S. C., Juliano, L., Saraiva, M. J., et al. (2012). Transthyretin is a metallopeptidase with an inducible active site. Biochemical Journal, 443(3), 769 - 778.
Gales, L., Cortes, L., Almeida, C., Melo, C. V., et al. (2005). Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: Trapping early oligomers of non-expanded ataxin-3. Journal of Molecular Biology, 353(3), 642 - 654.
Pires, R. H., Saraiva, M. J., Damas, A. M., & Kellermayer, M. S. Z. (2011). Structure and assembly-disassembly properties of wild-type transthyretin amyloid protofibrils observed with atomic force microscopy. Journal of Molecular Recognition, 24(3), 467 - 476.
Castro-Rodrigues, A. F., Gales, L., Saraiva, M. J., & Damas, A. M. (2011). Structural insights into a zinc-dependent pathway leading to Leu55Pro transthyretin amyloid fibrils. Acta Crystallographica Section D: Biological Crystallography, 67(12), 1035 - 1044.
Gales, L., Saraiva, M. J., & Damas, A. M. (2007). Structural basis for the protective role of sulfite against transthyretin amyloid formation. Biochimica et Biophysica Acta - Proteins and Proteomics, 1774(1), 59 - 64.
Sárkány, Z., Ikonen, T. P., Ferreira-Da-Silva, F., Saraiva, M. J., et al. (2011). Solution structure of the soluble receptor for advanced glycation end products (sRAGE). Journal of Biological Chemistry, 286(43), 37525 - 37534.
Almeida, M. R., Gales, L., Damas, A. M., Cardoso, I., & Saraiva, M. J. (2005). Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses. Current Drug Targets: CNS and Neurological Disorders, 4(5), 587 - 596.
Ferreira, C., Crespo, R., Martins, P. M., Gales, L., et al. (2011). Small temperature oscillations promote protein crystallization. CrystEngComm, 13(8), 3051 - 3056.
Martins, P. M., Pessoa, J., Sàrkàny, Z., Rocha, F., & Damas, A. M. (2008). Rationalizing protein crystallization screenings through water equilibration theory and protein solubility data. Crystal Growth and Design, 8(12), 4233 - 4243.
Neves, M. P., Cidade, H., Pinto, M., Silva, A. M. S., et al. (2011). Prenylated derivatives of baicalein and 3,7-dihydroxyflavone: Synthesis and study of their effects on tumor cell lines growth, cell cycle and apoptosis. European Journal of Medicinal Chemistry, 46(6), 2562 - 2574.
Crespo, R., Martins, P. M., Gales, L., Rocha, F., & Damas, A. M. (2010). Potential use of ultrasound to promote protein crystallization. Journal of Applied Crystallography, 43(6), 1419 - 1425.
Dethoup, T., Manoch, L., Kijjoa, A., Pinto, M., et al. (2007). Merodrimanes and other constituents from Talaromyces thailandiasis. Journal of Natural Products, 70(7), 1200 - 1202.
Vieira, L. M. M., Kijjoa, A., Silva, A. M. S., Mondranondra, I. - O., et al. (2004). Lanostanes and friedolanostanes from the bark of Garcinia speciosa. Phytochemistry, 65(4), 393 - 398.
Mairal, T., Nieto, J., Pinto, M., Almeida, M. R., et al. (2009). Iodine atoms: A new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors. PLoS ONE, 4(1).
Mairal, T., Nieto, J., Pinto, M., Almeida, M. R., et al. (2009). Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors. PLoS ONE, 4(1).
Gales, L., Almeida, M. R., Arsequell, G., Valencia, G., et al. (2008). Iodination of salicylic acid improves its binding to transthyretin. Biochimica et Biophysica Acta - Proteins and Proteomics, 1784(3), 512 - 517.
Gales, L., Macedo-Ribeiro, S., Arsequell, G., Valencia, G., et al. (2005). Human transthyretin in complex with iododiflunisal: Structural features associated with a potent amyloid inhibitor. Biochemical Journal, 388(2), 615 - 621.
Noborna, F., O'Callaghan, P., Hermansson, E., Zhang, X., et al. (2011). Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein. Proceedings of the National Academy of Sciences of the United States of America, 108(14), 5584 - 5589.
Crespo, R., Rocha, F. A., Damas, A. M., & Martins, P. M. (2012). A generic crystallization-like model that describes the kinetics of amyloid fibril formation. Journal of Biological Chemistry, 287(36), 30585 - 30594.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@ibmc.up.pt | © copyright 2010 ibmc